Impact of Rapid Molecular Diagnostic Testing on Outcomes of Patients With Vancomycin-Resistant Enterococcal Bacteremia
RMDT was associated with decreased time to receipt of active antimicrobial therapy in VRE bacteremia. There was no improvement in mortality associated with the use of RMDT. RMDT for VRE bacteremia may improve time to identification and treatment of VRE bacteremia but does not clearly improve clinical outcomes.
Authors
- Michael J. Satlin (ORCID: https://orcid.org/0000-0003-4711-5334)
- Lars F. Westblade (ORCID: https://orcid.org/0000-0003-3079-7674)
- Michael Hovan (ORCID: https://orcid.org/0000-0003-2494-7867)
- Matthew S. Simon (ORCID: https://orcid.org/0000-0003-3256-1681)
- Michael Burkitt (ORCID: https://orcid.org/0000-0002-2491-8698)
- Judith Hargrave
- Sierra Derti
- Stephen G. Jenkins
- Angela S De Cordova
Institutions
- Allegheny Health Network (US)
- University of Pittsburgh (US)
- Cornell University (US)
- Presbyterian Hospital (US)
- University of Pittsburgh Medical Center (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1093/ofid/ofaf757
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00